Bank of New York Mellon’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-3,181
| Closed | -$602K | – | 4658 |
|
|
2021
Q4 | $602K | Sell |
3,181
-94
| -3% | -$18.1K | ﹤0.01% | 3679 |
|
|
2021
Q3 | $662K | Buy |
3,275
+9
| +0.3% | +$1.89K | ﹤0.01% | 3642 |
|
|
2021
Q2 | $658K | Buy |
3,266
+15
| +0.5% | +$2.79K | ﹤0.01% | 3642 |
|
|
2021
Q1 | $570K | Buy |
3,251
+145
| +5% | +$26.2K | ﹤0.01% | 3615 |
|
|
2020
Q4 | $527K | Buy |
3,106
+125
| +4% | +$20.6K | ﹤0.01% | 3591 |
|
|
2020
Q3 | $483K | Sell |
2,981
-33
| -1% | -$5.37K | ﹤0.01% | 3506 |
|
|
2020
Q2 | $491K | Hold |
3,014
| – | – | ﹤0.01% | 3487 |
|
|
2020
Q1 | $386K | Sell |
3,014
-3,166
| -51% | -$426K | ﹤0.01% | 3495 |
|
|
2019
Q4 | $862K | Sell |
6,180
-36
| -0.6% | -$4.73K | ﹤0.01% | 3321 |
|
|
2019
Q3 | $733K | Buy |
6,216
+716
| +13% | +$89K | ﹤0.01% | 3340 |
|
|
2019
Q2 | $709K | Hold |
5,500
| – | – | ﹤0.01% | 3421 |
|
|
2019
Q1 | $707K | Sell |
5,500
-300
| -5% | -$37.9K | ﹤0.01% | 3378 |
|
|
2018
Q4 | $642K | Hold |
5,800
| – | – | ﹤0.01% | 3349 |
|
|
2018
Q3 | $789K | Hold |
5,800
| – | – | ﹤0.01% | 3404 |
|
|
2018
Q2 | $696K | Sell |
5,800
-360
| -6% | -$42.4K | ﹤0.01% | 3452 |
|
|
2018
Q1 | $741K | Buy |
6,160
+360
| +6% | +$45.2K | ﹤0.01% | 3373 |
|
|
2017
Q4 | $722K | Sell |
5,800
-1
| -0% | -$128 | ﹤0.01% | 3428 |
|
|
2017
Q3 | $778K | Buy |
5,801
+300
| +5% | +$39.1K | ﹤0.01% | 3365 |
|
|
2017
Q2 | $691K | Sell |
5,501
-29
| -0.5% | -$3.5K | ﹤0.01% | 3445 |
|
|
2017
Q1 | $659K | Buy |
5,530
+27
| +0.5% | +$3.16K | ﹤0.01% | 3443 |
|
|
2016
Q4 | $591K | Buy |
5,503
+1,001
| +22% | +$109K | ﹤0.01% | 3512 |
|
|
2016
Q3 | $518K | Buy |
4,502
+1,501
| +50% | +$171K | ﹤0.01% | 3516 |
|
|
2016
Q2 | $307K | Buy |
3,001
+1
| +0% | +$107 | ﹤0.01% | 3734 |
|
|
2016
Q1 | $311K | Buy |
3,000
+1,401
| +88% | +$146K | ﹤0.01% | 3631 |
|
|
2015
Q4 | $203K | Buy |
+1,599
| New | +$196K | ﹤0.01% | 3862 |
|
|
2015
Q3 | – | Sell |
-3,101
| Closed | -$418K | – | 4368 |
|
|
2015
Q2 | $418K | Buy |
3,101
+600
| +24% | +$79.7K | ﹤0.01% | 3696 |
|
|
2015
Q1 | $324K | Sell |
2,501
-900
| -26% | -$113K | ﹤0.01% | 3752 |
|
|
2014
Q4 | $392K | Hold |
3,401
| – | – | ﹤0.01% | 3707 |
|
|
2014
Q3 | $360K | Buy |
3,401
+1
| +0% | +$101 | ﹤0.01% | 3728 |
|
|
2014
Q2 | $324K | Hold |
3,400
| – | – | ﹤0.01% | 3720 |
|
|
2014
Q1 | $309K | Buy |
3,400
+1,000
| +42% | +$97.2K | ﹤0.01% | 3734 |
|
|
2013
Q4 | $212K | Buy |
+2,400
| New | +$201K | ﹤0.01% | 3838 |
|
|
2013
Q3 | – | Sell |
-4,044
| Closed | -$278K | – | 4157 |
|
|
2013
Q2 | $278K | Buy |
+4,044
| New | +$281K | ﹤0.01% | 3688 |
|
Other funds holding BBH
TIA
MJRIC
MCM
CCA
Bank of New York Mellon's BBH Position: Q1 2022 in Review
Bank of New York Mellon sold out of VanEck Biotech ETF (BBH) in Q1 2022, closing a stake of 3,181 shares — an estimated $602K sold.
Bank of New York Mellon first reported a position in BBH in Q2 2013 and held it in 33 quarters. The position peaked at $862K in Q4 2019. 115 funds tracked by Wall St. Rank hold BBH as of Q1 2022.
- Bank of New York Mellon reported no remaining VanEck Biotech ETF position as of Q1 2022 after selling out during the quarter.
- Bank of New York Mellon sold 3,181 VanEck Biotech ETF shares in Q1 2022, an estimated $602K.
- Bank of New York Mellon first reported a position in VanEck Biotech ETF in Q2 2013 and held it in 33 quarters.
- Bank of New York Mellon's VanEck Biotech ETF position peaked at $862K in Q4 2019.
- 115 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2022.
Based on Bank of New York Mellon's 13F filing for Q1 2022, filed 11 May 2022.